RHUMBLINE ADVISERS - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 148 filers reported holding DENALI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,489,007
-27.0%
169,124
+4.4%
0.00%
-20.0%
Q2 2023$4,780,088
+141868.8%
161,982
+10.8%
0.01%
+25.0%
Q1 2023$3,367
-15.3%
146,142
+2.2%
0.00%
-20.0%
Q4 2022$3,975
-99.9%
142,932
+11.7%
0.01%
-16.7%
Q3 2022$3,926,000
+13.6%
127,933
+8.9%
0.01%
+20.0%
Q2 2022$3,457,000
+10.6%
117,475
+20.9%
0.01%
+25.0%
Q1 2022$3,125,000
-27.5%
97,145
+0.5%
0.00%
-20.0%
Q4 2021$4,311,000
-12.3%
96,649
-0.8%
0.01%
-28.6%
Q3 2021$4,914,000
-34.0%
97,405
+2.7%
0.01%
-30.0%
Q2 2021$7,440,000
+82.0%
94,855
+32.5%
0.01%
+66.7%
Q1 2021$4,087,000
-38.7%
71,575
-10.1%
0.01%
-33.3%
Q4 2020$6,669,000
+135.3%
79,623
+0.7%
0.01%
+125.0%
Q3 2020$2,834,000
+28.9%
79,095
-13.0%
0.00%0.0%
Q2 2020$2,198,000
+90.5%
90,915
+37.9%
0.00%
+100.0%
Q1 2020$1,154,000
+4.3%
65,930
+3.8%
0.00%0.0%
Q4 2019$1,106,000
+15.1%
63,512
+1.2%
0.00%0.0%
Q3 2019$961,000
-27.0%
62,730
-1.0%
0.00%0.0%
Q2 2019$1,316,000
-5.8%
63,387
+5.3%
0.00%
-33.3%
Q1 2019$1,397,000
+11.1%
60,183
-1.1%
0.00%0.0%
Q4 2018$1,257,000
+51.6%
60,849
+59.6%
0.00%
+50.0%
Q3 2018$829,000
+235.6%
38,137
+135.3%
0.00%
Q2 2018$247,000
-9.9%
16,211
+16.6%
0.00%
-100.0%
Q1 2018$274,00013,9050.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders